Home/Filings/4/0001127602-23-015044
4//SEC Filing

Gordon Murdo 4

Accession 0001127602-23-015044

CIK 0000318154other

Filed

May 8, 8:00 PM ET

Accepted

May 9, 7:13 PM ET

Size

5.4 KB

Accession

0001127602-23-015044

Insider Transaction Report

Form 4
Period: 2023-05-05
Gordon Murdo
EVP, Global Commercial Ops
Transactions
  • Tax Payment

    Common Stock

    2023-05-05$231.89/sh623$144,46753,866 total
Footnotes (2)
  • [F1]These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,180 RSUs which will vest on 5/5/2024; 2,796 RSUs which will vest in installments of 1,377 on 4/30/2024 and 1,419 on 4/30/2025; 4,330 which will vest in installments of 1,428 on 5/2/2024, 1,429 on 5/2/2025, and 1,473 on 5/2/2026; and 4,237 RSUs which will vest in two installments of 1,398 on 5/2/2025 and 5/2/2026, and 1,441 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
  • [F2]These shares include 439 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Issuer

AMGEN INC

CIK 0000318154

Entity typeother

Related Parties

1
  • filerCIK 0001642156

Filing Metadata

Form type
4
Filed
May 8, 8:00 PM ET
Accepted
May 9, 7:13 PM ET
Size
5.4 KB